Moderna Stock No-Brainer After FDA Win: Buy or Not?
A recent FDA decision sparked a powerful rally in Moderna shares, but is the move enough to call it a no-brainer? Thi...
Discover which index funds are top rated for retirement in 2024 and why they matter for your portfolio. Learn about performance, fees, and diversification.
25,383 articlesA recent FDA decision sparked a powerful rally in Moderna shares, but is the move enough to call it a no-brainer? Thi...
The FBI director disclosed a late Strategy stock purchase, prompting questions about STOCK Act timing and potential c...
Anthropic’s looming IPO could reshape AI investing. With a private valuation near the hundreds of billions and big te...
AMD's quarterly results show data-center strength lifting the growth story. This piece maps a 5-year prediction stock...
When a high-profile investor makes a big move, questions follow. This guide cuts through the headlines to examine Ali...
Tom Lee argues Ethereum could reach a $5 trillion network value, a bold ethereum price prediction: predicts scenario ...
A rare market moment has many analysts talking about a stock market verge doing something we've never seen before in ...
IBM slumped 22% in early trading on a preliminary Q2 miss, igniting a wider tech sector selloff as analysts weigh AI ...
U.S. oil refiners are set for a historic profit surge as supply disruptions and stronger demand push refining margins...
Tesla pushed out a solid delivery quarter, but the stock didn’t follow. This article breaks down what the numbers mea...
Berkshire Hathaway’s surprise Alphabet investment signals a bold, long-term bet from Buffett. Learn the reasoning, ri...
A Google-backed study finds only 40% of U.S. workers casually use AI at work, with just 5% AI fluent. The result: big...